| Dr John Bernard Junod, MD | |
|
75 E Street Rd, Feasterville Trevose, PA 19053-6047 | |
| (267) 684-1047 | |
| Not Available |
| Full Name | Dr John Bernard Junod |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 38 Years |
| Location | 75 E Street Rd, Feasterville Trevose, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205839339 | NPI | - | NPPES |
| 0011689650006 | Medicaid | PA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | MD040084E (Pennsylvania) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Patient First Pennsylvania Medical Group Pllc | 5193900280 | 148 |
News Archive
It is not surprising that as our economy continues its freefall, we are feeling increasingly more stressed and worried.
University of Adelaide researchers have identified a likely molecular pathway that causes a group of untreatable neurodegenerative diseases, including Huntington's disease and Lou Gehrig's disease.
Epizyme today announced a worldwide strategic alliance with GlaxoSmithKline to discover, develop, and market novel small molecule therapeutics targeting histone methyltransferases, an important class of epigenetic enzymes, for the treatment of cancer and other diseases.
Because half of all instances of hearing loss are linked to genetic mutations, advanced gene research is an invaluable tool for uncovering causes of deafness - and one of the biggest hopes for the development of new therapies. Now Prof. Karen Avraham of the Sackler Faculty of Medicine at Tel Aviv University has discovered a significant mutation in a LINC family protein - part of the cells of the inner ear - that could lead to new treatments for hearing disorders.
BELLUS Health Inc. reported today its financial results for the first quarter ended March 31, 2010.
› Verified 1 days ago
| Entity Name | Patient First Pennsylvania Medical Group Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1194039560 PECOS PAC ID: 5193900280 Enrollment ID: O20110505000465 |
News Archive
It is not surprising that as our economy continues its freefall, we are feeling increasingly more stressed and worried.
University of Adelaide researchers have identified a likely molecular pathway that causes a group of untreatable neurodegenerative diseases, including Huntington's disease and Lou Gehrig's disease.
Epizyme today announced a worldwide strategic alliance with GlaxoSmithKline to discover, develop, and market novel small molecule therapeutics targeting histone methyltransferases, an important class of epigenetic enzymes, for the treatment of cancer and other diseases.
Because half of all instances of hearing loss are linked to genetic mutations, advanced gene research is an invaluable tool for uncovering causes of deafness - and one of the biggest hopes for the development of new therapies. Now Prof. Karen Avraham of the Sackler Faculty of Medicine at Tel Aviv University has discovered a significant mutation in a LINC family protein - part of the cells of the inner ear - that could lead to new treatments for hearing disorders.
BELLUS Health Inc. reported today its financial results for the first quarter ended March 31, 2010.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr John Bernard Junod, MD 5000 Cox Rd, Glen Allen, VA 23060-9263 Ph: (804) 968-5700 | Dr John Bernard Junod, MD 75 E Street Rd, Feasterville Trevose, PA 19053-6047 Ph: (267) 684-1047 |
News Archive
It is not surprising that as our economy continues its freefall, we are feeling increasingly more stressed and worried.
University of Adelaide researchers have identified a likely molecular pathway that causes a group of untreatable neurodegenerative diseases, including Huntington's disease and Lou Gehrig's disease.
Epizyme today announced a worldwide strategic alliance with GlaxoSmithKline to discover, develop, and market novel small molecule therapeutics targeting histone methyltransferases, an important class of epigenetic enzymes, for the treatment of cancer and other diseases.
Because half of all instances of hearing loss are linked to genetic mutations, advanced gene research is an invaluable tool for uncovering causes of deafness - and one of the biggest hopes for the development of new therapies. Now Prof. Karen Avraham of the Sackler Faculty of Medicine at Tel Aviv University has discovered a significant mutation in a LINC family protein - part of the cells of the inner ear - that could lead to new treatments for hearing disorders.
BELLUS Health Inc. reported today its financial results for the first quarter ended March 31, 2010.
› Verified 1 days ago
Mei Ling Zheng, CRNP Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 178 W Street Rd, Feasterville Trevose, PA 19053 Phone: 215-710-6490 | |
Dr. Jon Scott Fisher, D.O. Family Medicine Medicare: Medicare Enrolled Practice Location: 157 Bustleton Pike # 161, Feasterville Trevose, PA 19053 Phone: 215-322-0222 Fax: 215-322-0442 | |
Neelima M Kute, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 23 Bustleton Pike, Suite 200, Feasterville Trevose, PA 19053 Phone: 215-464-0770 Fax: 267-579-0720 | |
John Z Mcdonald, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 523 Bustleton Pike, Feasterville Trevose, PA 19053 Phone: 215-355-7900 Fax: 215-355-9005 | |
Alberto J Larrieu, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 1200 Bustleton Pike Ste 7, Feasterville Trevose, PA 19053 Phone: 267-288-5060 | |
Sean Thomas Duffy, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 75 E Street Rd, Feasterville Trevose, PA 19053 Phone: 267-684-1047 |